Ken Fisher's ABBV Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 628,338 shares of AbbVie Inc. (ABBV) worth $143.57 M, representing 0.05% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Ken Fisher has maintained a long-term strategic position in ABBV, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2014, adding 477,470 shares. Largest reduction occurred in Q1 2014, reducing 415,382 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's AbbVie (ABBV) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbbVie (ABBV) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +352,487 | Add 127.78% | 628,338 | $228.49 |
| Q3 2025 | -7,729 | Reduce 2.73% | 275,851 | $231.54 |
| Q2 2025 | -74,056 | Reduce 20.71% | 283,580 | $185.62 |
| Q1 2025 | +314,403 | Add 727.23% | 357,636 | $209.52 |
| Q4 2024 | +4,319 | Add 11.10% | 43,233 | $177.70 |
| Q3 2024 | -885 | Reduce 2.22% | 38,914 | $197.48 |
| Q2 2024 | +5,876 | Add 17.32% | 39,799 | $171.52 |
| Q1 2024 | +14 | Add 0.04% | 33,923 | $182.10 |
| Q4 2023 | -3,065 | Reduce 8.29% | 33,909 | $154.97 |
| Q3 2023 | +6,562 | Add 21.58% | 36,974 | $149.06 |
| Q2 2023 | +2,920 | Add 10.62% | 30,412 | $134.73 |
| Q1 2023 | -2,714 | Reduce 8.98% | 27,492 | $159.37 |
| Q4 2022 | -6,303 | Reduce 17.26% | 30,206 | $161.62 |
| Q3 2022 | +751 | Add 2.10% | 36,509 | $134.21 |
| Q2 2022 | +2,108 | Add 6.26% | 35,758 | $153.17 |
| Q1 2022 | -3,508 | Reduce 9.44% | 33,650 | $162.11 |
| Q4 2021 | +1,884 | Add 5.34% | 37,158 | $135.39 |
| Q3 2021 | +3,460 | Add 10.88% | 35,274 | $107.87 |
| Q2 2021 | +352 | Add 1.12% | 31,814 | $112.65 |
| Q1 2021 | -1,598 | Reduce 4.83% | 31,462 | $108.23 |
| Q4 2020 | +3,380 | Add 11.39% | 33,060 | $107.14 |
| Q3 2020 | -1,741 | Reduce 5.54% | 29,680 | $87.60 |
| Q2 2020 | +2,937 | Add 10.31% | 31,421 | $98.18 |
| Q1 2020 | -271,252 | Reduce 90.50% | 28,484 | $76.18 |
| Q4 2019 | -120,362 | Reduce 28.65% | 299,736 | $88.54 |
| Q3 2019 | -3,778 | Reduce 0.89% | 420,098 | $75.72 |
| Q2 2019 | -268,584 | Reduce 38.79% | 423,876 | $72.72 |
| Q1 2019 | -120,616 | Reduce 14.83% | 692,460 | $80.59 |
| Q4 2018 | -3,274 | Reduce 0.40% | 813,076 | $92.19 |
| Q3 2018 | +15,559 | Add 1.94% | 816,350 | $94.58 |
| Q2 2018 | +24,999 | Add 3.22% | 800,791 | $92.65 |
| Q1 2018 | +163,142 | Add 26.63% | 775,792 | $94.65 |
| Q4 2017 | -70,624 | Reduce 10.34% | 612,650 | $96.71 |
| Q3 2017 | -3,245 | Reduce 0.47% | 683,274 | $88.86 |
| Q2 2017 | +3,604 | Add 0.53% | 686,519 | $72.51 |
| Q1 2017 | -13,654 | Reduce 1.96% | 682,915 | $65.16 |
| Q4 2016 | +12,527 | Add 1.83% | 696,569 | $62.62 |
| Q3 2016 | -9,352 | Reduce 1.35% | 684,042 | $63.07 |
| Q2 2016 | -49,890 | Reduce 6.71% | 693,394 | $64.35 |
| Q1 2016 | -191,820 | Reduce 20.51% | 743,284 | $59.51 |
| Q4 2015 | +7,145 | Add 0.77% | 935,104 | $59.24 |
| Q3 2015 | -78,720 | Reduce 7.82% | 927,959 | $54.41 |
| Q2 2015 | -4,077 | Reduce 0.40% | 1.01 M | $67.19 |
| Q1 2015 | +9,651 | Add 0.96% | 1.01 M | $58.54 |
| Q4 2014 | +1,337 | Add 0.13% | 1 M | $65.44 |
| Q3 2014 | -104,841 | Reduce 9.49% | 999,768 | $57.76 |
| Q2 2014 | +477,470 | Add 76.13% | 1.1 M | $56.44 |
| Q1 2014 | -415,382 | Reduce 39.84% | 627,139 | $51.40 |
| Q4 2013 | -23,411 | Reduce 2.20% | 1.04 M | $52.81 |
| Q3 2013 | -81,185 | Reduce 7.08% | 1.07 M | $44.73 |
| Q2 2013 | +1.15 M | Add 0.00% | 1.15 M | $41.34 |
Ken Fisher's AbbVie Investment FAQs
Ken Fisher first purchased AbbVie Inc. (ABBV) in Q2 2013, acquiring 1,147,117 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held AbbVie Inc. (ABBV) for 51 quarters since Q2 2013.
Ken Fisher's largest addition to AbbVie Inc. (ABBV) was in Q2 2013, adding 1,147,117 shares worth $47.42 M.
According to the latest 13F filing for Q4 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 628,338 shares of AbbVie Inc. (ABBV), valued at approximately $143.57 M.
As of the Q4 2025 filing, AbbVie Inc. (ABBV) represents approximately 0.05% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in AbbVie Inc. (ABBV) was 1,147,117 shares, as reported at the end of Q2 2013.